FIELD: immunology, medicine.
SUBSTANCE: invention relates to pharmaceutical composition containing dendrite cells loaded with al least five testicle cancer antigen and containing no line-specific differentiating antigens. Aldo disclosed are isolated cell line expressing number of five testicle cancer antigen expressing no differentiating antigens and method for inducing of immune response in human by using of said composition.
EFFECT: new effective pharmaceutical composition for inducing of immune response.
56 cl, 16 dwg, 5 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE FOR ANTITUMOR IMMUNITY STIMULATION | 2000 |
|
RU2192884C2 |
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
| PROTEIN-PEPTIDE ANTITUMOR COMPOSITION, CELL PREPARATION ACTIVATED THEREWITH AND METHOD FOR TUMOR PROPHYLAXIS OR TREATMENT | 2004 |
|
RU2283129C1 |
| CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
| HUMAN MELANOMA CELL LINE mel Ch, USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2373279C1 |
| CELL LINE OF HUMAN MELANOMA mel Cher, USED FOR OBTAINING ANTI-TUMOR VACCINES | 2008 |
|
RU2364624C1 |
| HUMAN MELANOMA CELL LINES mel Si, USED FOR MAKING TUMOUR VACCINE | 2008 |
|
RU2363734C1 |
| CELL LINE OF HUMAN MELANOMA mel Mtp USED FOR MAKING ANTICANCER VACCINES | 2008 |
|
RU2360963C1 |
| CELL LINE OF HUMAN MELANOMA mel Rac, APPLIED FOR OBTAINING ANTITUMOUR VACCINE | 2009 |
|
RU2402602C1 |
| HUMAN MELANOMA CELLULAR LINE mel Kor USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287578C1 |
